H.J. Keizer

Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group

Axel Le Cesne, Ian Judson, D. Crowther et al. · Journal of Clinical Oncology · 2000 · 258 citations

Medicine, Oncology, Pharmacology +15

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.

Ewout W. Steyerberg, H.J. Keizer, Sophie D. Fosså et al. · Journal of Clinical Oncology · 1995 · 252 citations · Full text

Medicine, Oncology, Pathology +15

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Ole S. Nielsen, Ian Judson, Q. van Hoesel et al. · European Journal of Cancer · 2000 · 150 citations

Medicine, Oncology, Radiation Oncology +11

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

L Švancárová, Jean‐Yves Blay, Ian Judson et al. · European Journal of Cancer · 2002 · 119 citations

Medicine, Oncology, Chemotherapy +14

Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial

Ilfet Songun, H.J. Keizer, J. Hermans et al. · European Journal of Cancer · 1999 · 111 citations

Medicine, Oncology, Surgery +8